The Interplay Between CB2 and NMDA Receptors in Parkinson’s Disease

Irene Reyes‐Resina(Biomedical Research Networking Center on Neurodegenerative Diseases), Gemma Navarro(Biomedical Research Networking Center on Neurodegenerative Diseases)
International Journal of Molecular Sciences
September 26, 2025
10.3390/ijms26199419
Cited by 1

Related Papers

Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase
|Nature Communications|2018|125
Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer’s Disease
|Cells|2020|49
Expression of Melatonin and Dopamine D3 Receptor Heteromers in Eye Ciliary Body Epithelial Cells and Negative Correlation with Ocular Hypertension
|Cells|2020|21
Antagonization of OX1 Receptor Potentiates CB2 Receptor Function in Microglia from APPSw/Ind Mice Model
|International Journal of Molecular Sciences|2022|14
Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons
|International Journal of Molecular Sciences|2022|13